| Exhibit No. | Description                                                                                                                                                                                                                                                                                                                                                     |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|             | 10.38#<br>Zymeworks BC Inc. and Zymeworks Management Inc. (incorporated by reference to Exhibit 10.1 to the                                                                                                                                                                                                                                                     |
|             | Company's Current Report on Form 8-K filed with the SEC on December 30, 2022).                                                                                                                                                                                                                                                                                  |
|             | 10.39#<br>Zymeworks BC Inc. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K<br>filed with the SEC on January 5, 2024).                                                                                                                                                                                                   |
|             | 10.40# - Amended and Restated Employment Agreement by and between Zymeworks BC Inc. and Christopher Astle,<br>dated February 24, 2022 (incorporated by reference to Exhibit 10.1 to Zymeworks BC Inc.'s Current Report on<br>Form 8-K filed with the SEC on February 25, 2022).                                                                                 |
|             | 10.41#<br>Zymeworks BC Inc., dated November 17, 2022 (incorporated by reference to Exhibit 10.1 to the Company's<br>Current Report on Form 8-K filed with the SEC on November 18, 2022).                                                                                                                                                                        |
| 10.42 #     | Employment Agreement by and between Zymeworks Pharmaceuticals Limited and Jeffrey Smith, dated January<br>3. 2023.                                                                                                                                                                                                                                              |
| 10.43 #     | Letter, dated January 5, 2024, from Zymeworks Inc. to Jeffrey Smith.                                                                                                                                                                                                                                                                                            |
| 10.44#      | Executive Incentive Compensation Plan (incorporated by reference to Exhibit 10.64 to the Company's Annual<br>Report on Form 10-K filed with the SEC on March 7, 2023).                                                                                                                                                                                          |
|             | 10.45#<br>Company's Registration Statement on Form S-4 filed with the SEC on August 19, 2022).                                                                                                                                                                                                                                                                  |
|             | 10.46#<br>Moore, dated July 14, 2023 (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on<br>Form 10-Q filed with the SEC on August 10, 2023).                                                                                                                                                                                       |
|             | 10.47<br>Company's Registration Statement on Form S-4 filed with the SEC on August 19, 2022).                                                                                                                                                                                                                                                                   |
|             | 10.48<br>Registration Statement on Form S-4 filed with the SEC on August 19, 2022).                                                                                                                                                                                                                                                                             |
|             | 10.49# Inducement Stock Option and Equity Compensation Plan of the Company (and forms of agreements<br>thereunder).                                                                                                                                                                                                                                             |
|             | 10.50# _ Amended and Restated Stock Option and Equity Compensation Plan of the Company (and forms of agreements<br>thereunder) and UK Sub-Plan to the Amended and Restated Stock Option and Equity Compensation Plan of the<br>Company (and forms of agreements thereunder).                                                                                    |
|             | 10.51# Second Amended and Restated Employee Stock Option Plan of the Company (and forms of agreements<br>thereunder) (incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K12B filed<br>with the SEC on October 13, 2022).                                                                                                      |
|             | 10.52# _ Amended and Restated Employee Stock Purchase Plan of the Company (incorporated by reference to Exhibit<br>10.5 to the Company's Current Report on Form 8-K12B filed with the SEC on October 13, 2022).                                                                                                                                                 |
|             | 10.53 Sales Agreement, dated November 9, 2022, by and between the Company and Cantor Fitzgerald & Co.<br>(incorporated by reference to Exhibit 1.1 to the Company's Current Report on Form 8-K filed with the SEC on<br>November 9, 2022).                                                                                                                      |
|             | 10.54* - Amended and Restated License and Collaboration Agreement, dated May 15, 2023, by and between Zymeworks<br>BC Inc. and Jazz Pharmaceuticals Ireland Limited (incorporated by reference to Exhibit 10.1 to the Company's<br>Current Report on Form 8-K filed with the SEC on May 16, 2023).                                                              |
|             | 10.55*, + Stock and Asset Purchase Agreement, dated April 25, 2023, by and between Zymeworks BC Inc., Zymeworks<br>Biopharmaceuticals Inc., Zymeworks Zanidatamab Inc., and Jazz Pharmaceuticals, Inc (incorporated by<br>reference to Exhibit 10.4 to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 10,<br>2023).                   |
|             | 10.56*, + Amendment No. 1 to Stock and Asset Purchase Agreement, dated May 15, 2023, by and between Zymeworks<br>BC Inc., Zymeworks Biopharmaceuticals Inc., Zymeworks Zanidatamab Inc., and Jazz Pharmaceuticals, Inc.<br>(incorporated by reference to Exhibit 10.5 to the Company's Quarterly Report on Form 10-Q filed with the SEC<br>on August 10, 2023). |